{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:33:45Z","timestamp":1791650025746,"version":"4.3.4"},"reference-count":30,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Hereditary transthyretin amyloidosis (ATTRv) is a rare, autosomal dominant multisystem disease caused by pathogenic variants in the transthyretin (TTR) gene. Although ATTRv is classically categorized into \u201ccardiac\u201d and \u201cneurologic\u201d phenotypes, recent evidence suggests a more complex and overlapping disease spectrum. Objectives: This study investigates the relationship between neurological staging and cardiac involvement through an integrated assessment of patients with confirmed TTR mutations. Methods and Results: Fifty-eight patients with genetically confirmed ATTRv (41% female, mean age 60 \u00b1 15 years) were evaluated. Genotypes included Phe64Leu, Val30Met, Val122Ile, and others. Patients were stratified by neurological stage: G0 (asymptomatic carriers), G1 (symptomatic but ambulatory), and G2 (requiring walking support). Cardiac assessment included clinical evaluation, echocardiography with tissue Doppler, global longitudinal strain (GLS), and NT-proBNP levels. Cardiac markers worsened with neurological stage. NT-proBNP, left ventricular mass index, maximal wall thickness, and E\/E\u2032 ratio increased progressively, while GLS declined (G0: \u201319%, G1: \u201314%, G2: \u201313%; p &lt; 0.001), indicating a progressive structural and functional myocardial disease. Ejection fraction remained preserved. Neurological stage independently predicted cardiac dysfunction after age adjustment. Conclusions: This is the first study to assess cardiac abnormalities across neurological stages in a well-characterized cohort of ATTRv patients. Cardiac involvement in ATTRv begins early, even in asymptomatic carriers, and progresses with neurological deterioration. GLS and diastolic parameters are sensitive indicators of early myocardial dysfunction, highlighting the need for integrated neurologic and cardiac monitoring in all patients with ATTRv, regardless of initial phenotype.<\/jats:p>","DOI":"10.3390\/diagnostics15172143","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:25:57Z","timestamp":1756189557000},"page":"2143","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Parallel Neurological and Cardiac Progression in Hereditary Transthyretin Amyloidosis: An Integrated Clinical and Imaging Study"],"prefix":"10.3390","volume":"15","author":[{"given":"Grazia","family":"Canciello","sequence":"first","affiliation":[{"name":"Department of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9672-4577","authenticated-orcid":false,"given":"Stefano","family":"Tozza","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Reproductive and Odontostomatological Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo","family":"Ordine","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigida","family":"Napolitano","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Reproductive and Odontostomatological Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagiovanna","family":"Castiglia","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Reproductive and Odontostomatological Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pacella","sequence":"additional","affiliation":[{"name":"Department of Public Health, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5025-6993","authenticated-orcid":false,"given":"Raffaella","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0565-7127","authenticated-orcid":false,"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiore","family":"Manganelli","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Reproductive and Odontostomatological Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9819-0401","authenticated-orcid":false,"given":"Maria-Angela","family":"Losi","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/ejhf.2589","article-title":"Prevalence and clinical outcomes of transthyretin amyloidosis: A systematic review and meta-analysis","volume":"24","author":"Antonopoulos","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10072-020-04889-2","article-title":"Hereditary transthyretin amyloidosis overview","volume":"43","author":"Manganelli","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: A model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jns.12451","article-title":"The neuropathy in hereditary transthyretin amyloidosis: A narrative review","volume":"26","author":"Tozza","year":"2021","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fumagalli, C., Longhi, S., Aimo, A., Argir\u00f2, A., Barilaro, A., Biagini, E., Biagioni, G., Ceccanti, M., Cipriani, A., and Chimenti, C. (2025). Change in prevalence of ATTR variants in Italy\u2014Results from a National Survey. Eur. Hear. J. Qual. Care Clin. Outcomes, qcaf024.","DOI":"10.1093\/ehjqcco\/qcaf024"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/mus.28414","article-title":"Peripheral Nervous System Involvement of Hereditary Transthyretin Amyloidosis in the United States: A Multi-Center Perspective","volume":"72","author":"Desai","year":"2025","journal-title":"Muscle Nerve"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: An Italian perspective","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s10072-023-07140-w","article-title":"Heterogenous electrophysiological features in early stage of hereditary transthyretin","volume":"45","author":"Tozza","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Tozza, S., Severi, D., Palumbo, G., Provitera, V., Ruggiero, L., Dubbioso, R., Iodice, R., Nolano, M., and Manganelli, F. (2022). Quantitative Sensory Testing in Late-Onset ATTRv Presymptomatic Subjects: A Single Center Experience. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112877"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13023-020-01633-z","article-title":"Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: A multicenter Italian consensus","volume":"15","author":"Grandis","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s10072-024-07494-9","article-title":"Long-term treatment of hereditary transthyretin amyloidosis with patisiran: Multicentre, real-world experience in Italy","volume":"45","author":"Gentile","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12265-019-09911-3","article-title":"Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging","volume":"13","author":"Losi","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"131575","DOI":"10.1016\/j.ijcard.2023.131575","article-title":"Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy","volume":"395","author":"Losi","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Canciello, G., Pate, S., Sannino, A., Borrelli, F., Todde, G., Grayburn, P., Losi, M.-A., and Esposito, G. (2023). Pitfalls and Tips in the Assessment of Aortic Stenosis by Transthoracic Echocardiraphy. Diagnostics, 13.","DOI":"10.3390\/diagnostics13142414"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group; developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Canciello, G., Lombardi, R., Borrelli, F., Ordine, L., Chen, S.-N., Santoro, C., Frisso, G., di Napoli, S., Polizzi, R., and Cristiano, S. (2024). Echocardiographic Strain Abnormalities Precede Left Ventricular Hypertrophy Development in Hypertrophic Cardiomyopathy Mutation Carriers. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158128"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13023-024-03473-7","article-title":"Global longitudinal strain in pre-symptomatic patients with mutation for transthyretin amyloidosis","volume":"19","author":"Canciello","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.echo.2011.03.006","article-title":"American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography","volume":"24","author":"Nagueh","year":"2011","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrcardio.2010.67","article-title":"Transthyretin-related amyloidoses and the heart: A clinical overview","volume":"7","author":"Rapezzi","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur. J. Hear. Fail."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13506129.2018.1556156","article-title":"Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations","volume":"26","author":"Damy","year":"2019","journal-title":"Amyloid"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tozza, S., and Canciello, G. (2025). In response to Fumagalli et al. Eur. Hear. J. Qual. Care Clin. Outcomes, qcaf057.","DOI":"10.1093\/ehjqcco\/qcaf057"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jamacardio.2016.5864","article-title":"Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model","volume":"2","author":"Arvanitis","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/13506129.2017.1391086","article-title":"Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure","volume":"24","author":"Arvanitis","year":"2017","journal-title":"Amyloid"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2020.03.007","article-title":"Utility of Biomarkers in Cardiac Amyloidosis","volume":"8","author":"Abraham","year":"2020","journal-title":"JACC Hear. Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.echo.2022.06.006","article-title":"Practical Points for Echocardiography in Cardiac Amyloidosis","volume":"35","author":"Cuddy","year":"2022","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1097\/HJH.0000000000000624","article-title":"The mechanism of reduced longitudinal left ventricular systolic function in hypertensive patients with normal ejection fraction","volume":"33","author":"Fazakas","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ehf2.12511","article-title":"Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: A systematic review and meta-analysis","volume":"6","author":"Brownrigg","year":"2019","journal-title":"ESC Hear. Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40119-023-00344-3","article-title":"Clinical and Genotype Characteristics and Symptom Migration in Patients with Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey","volume":"13","author":"Dispenzieri","year":"2024","journal-title":"Cardiol. Ther."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/17\/2143\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:32:16Z","timestamp":1760034736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/17\/2143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":30,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["diagnostics15172143"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15172143","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]}}}